CLINUVEL PHARMS (CLVLF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 16 34 sessions, September 3, 2025 to September 4, 2026
- Largest daily move
- -25.7% close of April 14, 2026
- 1-year change
- -20.9% closing prices, September 3, 2025 to September 4, 2026
Company Description
CLINUVEL PHARMS (OTC: CLVLF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $308.9M.
CLVLF has declined 20.9% over the past year. The last closing price was $5.89.
This page collects what Stock Titan holds for CLVLF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CLINUVEL PHARMS (CLVLF) closed at $5.89 on September 4, 2026. Over the past 12 months, the price has lost 20.9%.
CLVLF Metrics & Rankings
Price returns through September 4, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
CLINUVEL PHARMS has filed 10 recent SEC filings, including 9 Form 6-K, 1 Form 424B3. The most recent filing was submitted on August 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CLVLF SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in CLINUVEL PHARMS (CLVLF) currently stands at 2.3 million shares, down 2.4% from the previous reporting period, representing 5.6% of the float. Since September 2025, short interest has increased by 50.9%. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for CLINUVEL PHARMS (CLVLF) currently stands at 1000.0 days, up 412% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 195.3 to 1000.0 days.
CLVLF Company Profile & Sector Positioning
CLINUVEL PHARMS (CLVLF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.